Evidence map›Paper›PMID 36697012›Full record

ArticleClinical medicine (London, England)2023

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists.

Rippie K Tutika, James A Bennett, Jean Abraham, Katie Snape, Katrina Tatton-Brown, Zoe Kemp, Ellen Copson, Mark R Openshaw

Abstract read
In one paragraph

Article in Clinical medicine (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Formalised curiosity.Clinical medicine (London, England) · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Rippie K TutikaQueen Elizabeth Hospital Birmingham, Birmingham, UK.
James A BennettRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Jean AbrahamUniversity of Cambridge, Cambridge, UK.
Katie SnapeSt George's Hospital, London UK, and The Institute of Cancer Research, London, UK.
Katrina Tatton-BrownSt George's Hospital, London, UK, and The Institute of Cancer Research, London, UK.
Zoe KempRoyal Marsden Hospital, London, UK.
Ellen CopsonUniversity of Southampton, Southampton, UK.
Mark R OpenshawQueen Elizabeth Hospital Birmingham, Birmingham, UK, and Royal Marsden Hospital NHS Trust, London, UK mropenshaw@doctors.org.uk.

Funding

Cancer Research UK 27223
6 · The paper itself

Abstract

objectiveGenomics is rapidly changing treatment paradigms for cancers, obligating oncologists to have good genomics knowledge. Through this survey, we aimed to assess the current understanding of cancer genomics among UK oncologists.

methodsWe conducted a web-based nation-wide self-assessment survey of the cancer genomics knowledge of UK clinical and medical oncology trainees and consultants.

resultsIn total, 150 oncologists (81 consultants and 69 trainees) responded, representing 10% of UK oncologists.Formal training in genomics had not been received by 38.7% of oncologists and 92.7% identified a need for additional genomics training.In total, 71.3% self-reported to have good knowledge of defining somatic and germline mutations, falling to 35.3% for understanding principles of gene expression and regulation. Knowledge of cancer-predisposing syndromes was highest for Lynch syndrome (40.7% good knowledge) and lowest for multiple endocrine neoplasia (14.0% good knowledge).Overall, 49.0% of respondents had consented patients for germline testing, but 80.7% reported a lack of training in genetic counselling.

conclusionLarge knowledge gaps have been identified through this survey, highlighting the need for incorporation of improved formal training in cancer genomics for consultants and trainees, with an aim to equip oncologists for advances in clinical practice and to take up genetic mainstreaming confidently.

Indexed as

NeoplasmsOncologistsGenomicsHumansMedical OncologySurveys and QuestionnairesUnited Kingdomgenomicsgermline geneticsmainstreamingoncologysomatic genetics

Identifiers

PMID36697012
PMCPMC11046524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.